Revvity Inc at Goldman Sachs Healthcare Conference Transcript
All right. Good morning, everyone. I'm Evie Koslosky, the life science tools and diagnostics analyst here at Goldman Sachs. I'm joined here by Prahlad Singh, the President and CEO of Revvity. Thank you so much for being here.
Questions & Answers
Maybe to kick us off, you had a solid start to the year, growth driven by both Diagnostics and Life Sciences. Maybe start by walking through some of the key takeaways from the quarter and how things have progressed since then.
Yeah, good morning. Just as we look at the businesses, as you said, we had a great start to the year. On the Diagnostics side, our reproductive health franchise continues to do very well. Immunodiagnostic to ex China was performing well across other geographies. On the Life Sciences side, (inaudible) single, our reagents business grew low single (inaudible)
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
